76 related articles for article (PubMed ID: 21255834)
1. Correlation among nuclear localization of NuMA-RARα, deregulation of gene expression and leukemic phenotype of hCG-NuMA-RARα transgenic mice.
Sukhai MA; Thomas M; Hamadanizadeh SA; Xuan Y; Wells RA; Kamel-Reid S
Leuk Res; 2011 May; 35(5):670-6. PubMed ID: 21255834
[TBL] [Abstract][Full Text] [Related]
2. Evidence of functional interaction between NuMA-RARalpha and RXRalpha in an in vivo model of acute promyelocytic leukemia.
Sukhai MA; Thomas M; Xuan Y; Chan LS; Hamadanizadeh SA; Zhang T; Bharadwaj RR; Schuh AC; Wells RA; Kamel-Reid S
Oncogene; 2008 Aug; 27(34):4666-77. PubMed ID: 18408763
[TBL] [Abstract][Full Text] [Related]
3. The Retinoic acid receptor alpha (RARalpha) chimeric proteins PML-, PLZF-, NPM-, and NuMA-RARalpha have distinct intracellular localization patterns.
Hummel JL; Zhang T; Wells RA; Kamel-Reid S
Cell Growth Differ; 2002 Apr; 13(4):173-83. PubMed ID: 11971817
[TBL] [Abstract][Full Text] [Related]
4. [hCG-PLZF-RARalpha/hCG-RARalpha-PLZF transgenic mice developing into leukemia].
Chen LJ; Dong Y; Chen SY; Zhang L; Zhou GB; Chen B; Wang L; Chen Z; Chen SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):924-31. PubMed ID: 16403252
[TBL] [Abstract][Full Text] [Related]
5. Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RARalpha.
Sukhai MA; Wu X; Xuan Y; Zhang T; Reis PP; Dubé K; Rego EM; Bhaumik M; Bailey DJ; Wells RA; Kamel-Reid S; Pandolfi PP
Oncogene; 2004 Jan; 23(3):665-78. PubMed ID: 14737102
[TBL] [Abstract][Full Text] [Related]
6. Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.
Walter MJ; Park JS; Ries RE; Lau SK; McLellan M; Jaeger S; Wilson RK; Mardis ER; Ley TJ
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12513-8. PubMed ID: 16113082
[TBL] [Abstract][Full Text] [Related]
7. Modeling acute promyelocytic leukemia in the mouse: new insights in the pathogenesis of human leukemias.
Merghoub T; Gurrieri C; Piazza F; Pandolfi PP
Blood Cells Mol Dis; 2001; 27(1):231-48. PubMed ID: 11358384
[TBL] [Abstract][Full Text] [Related]
8. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
Bräuer-Hartmann D; Hartmann JU; Wurm AA; Gerloff D; Katzerke C; Verga Falzacappa MV; Pelicci PG; Müller-Tidow C; Tenen DG; Niederwieser D; Behre G
Cancer Res; 2015 Aug; 75(16):3411-24. PubMed ID: 26041820
[TBL] [Abstract][Full Text] [Related]
9. Essential role for the dimerization domain of NuMA-RARalpha in its oncogenic activities and localization to NuMA sites within the nucleus.
Dong S; Qiu J; Stenoien DL; Brinkley WR; Mancini MA; Tweardy DJ
Oncogene; 2003 Feb; 22(6):858-68. PubMed ID: 12584566
[TBL] [Abstract][Full Text] [Related]
10. Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia.
Hummel JL; Wells RA; Dubé ID; Licht JD; Kamel-Reid S
Oncogene; 1999 Jan; 18(3):633-41. PubMed ID: 9989813
[TBL] [Abstract][Full Text] [Related]
11. The theory of APL.
Piazza F; Gurrieri C; Pandolfi PP
Oncogene; 2001 Oct; 20(49):7216-22. PubMed ID: 11704849
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752
[TBL] [Abstract][Full Text] [Related]
13. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice.
Zimonjic DB; Pollock JL; Westervelt P; Popescu NC; Ley TJ
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13306-11. PubMed ID: 11087871
[TBL] [Abstract][Full Text] [Related]
14. Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains.
Grignani F; Testa U; Rogaia D; Ferrucci PF; Samoggia P; Pinto A; Aldinucci D; Gelmetti V; Fagioli M; Alcalay M; Seeler J; Grignani F; Nicoletti I; Peschle C; Pelicci PG
EMBO J; 1996 Sep; 15(18):4949-58. PubMed ID: 8890168
[TBL] [Abstract][Full Text] [Related]
15. [hCG-PLZF-RARA transgenic mice develop leukemia resembling human chronic myeloid leukemia].
Meng X; Cheng G; Wang L
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):22-5. PubMed ID: 11776589
[TBL] [Abstract][Full Text] [Related]
16. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.
Kelly LM; Kutok JL; Williams IR; Boulton CL; Amaral SM; Curley DP; Ley TJ; Gilliland DG
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8283-8. PubMed ID: 12060771
[TBL] [Abstract][Full Text] [Related]
17. [Detection of PML/RARalpha gene transcripts in 46 newly diagnosed acute promyelocytic leukemia patients by real-time quantitative reverse-transcription polymerase chain reaction].
Zhu HH; Liu YR; Qin YZ; Li JL; Chang Y; Wang YZ; Shan FX; Jiang B; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):1-5. PubMed ID: 17490509
[TBL] [Abstract][Full Text] [Related]
18. PML/RARalpha fusion protein mediates the unique sensitivity to arsenic cytotoxicity in acute promyelocytic leukemia cells: Mechanisms involve the impairment of cAMP signaling and the aberrant regulation of NADPH oxidase.
Li L; Wang J; Ye RD; Shi G; Jin H; Tang X; Yi J
J Cell Physiol; 2008 Nov; 217(2):486-93. PubMed ID: 18636556
[TBL] [Abstract][Full Text] [Related]
19. In vivo analysis of the molecular genetics of acute promyelocytic leukemia.
Pandolfi PP
Oncogene; 2001 Sep; 20(40):5726-35. PubMed ID: 11607822
[TBL] [Abstract][Full Text] [Related]
20. [Transcriptional regulation of BHLHB2 induced by PML-RARα].
Jia XH; Yang WT; Zhu XH; Yang XW; Zhang J; Wang KK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):1005-9. PubMed ID: 21867633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
